FMC benefits from its efforts to strengthen its product portfolio through new product launches and its restructuring and cost-reduction program.
While FMC faces headwinds from pricing and cost pressures, it gains on its efforts to strengthen its product portfolio and restructuring actions.
Dodhylex active by FMC is a key improvement for the agriculture industry because it combats resistant grass weeds.
Review FMC's (FMC) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Although the revenue and EPS for FMC (FMC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
FMC Corporation (NYSE:FMC ) Q2 2024 Earnings Conference Call August 1, 2024 9:00 AM ET Company Participants Curt Brooks - Director of IR Pierre Brondeau - Chairman and the CEO Andrew Sandifer - EVP and CFO Ronaldo Pereira - President Conference Call Participants Christopher Parkinson - Wolfe Research Partners Josh Spector - UBS Vincent Andrews - Morgan Stanley Arun Viswanathan - RBC Capital Frank Mitsch - Fermium Research Richard Garchitorena - Wells Fargo Edlain Rodriguez - Mizuho Benjamin Theurer - Barclays Operator Good morning and welcome to the Second Quarter 2024 Earnings Call for FMC Corporation. This event is being recorded and all participants are in listen-only mode.
FMC sees improved demand during the second quarter, leading to an increase in sales volumes and the top line.
FMC (FMC) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.50 per share a year ago.
FMC Corporation FMC recently declared a regular quarterly dividend of 58 cents per share, payable on Oct. 17, to shareholders of record as of the close of business on Sept. 30.
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC´s shares more than halved from post-pandemic highs due to leverage, de-stocking trends, and patent issues, making it a huge underperformer. The struggles are real, but the company guides for a recovery in the second half of the year, while divesting some assets to create liquidity. While management does not have credibility on its side, the risk-reward looks compelling, certainly if improvements are delivered upon.
FMC is selling its Global Specialty Solutions business to Envu for $350 million to focus on its core business.